Clinical Trials Browser

Phase 1/2 × Relapsed Pediatric Solid Tumor × pazopanib × Clear all

NCT03628131 2018-09-19

Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Relapsed Pediatric Solid Tumor